424.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MDGL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$422.99
Aprire:
$425.7
Volume 24 ore:
376.41K
Relative Volume:
1.00
Capitalizzazione di mercato:
$9.42B
Reddito:
-
Utile/perdita netta:
$-518.67M
Rapporto P/E:
-16.89
EPS:
-25.12
Flusso di cassa netto:
$-438.32M
1 W Prestazione:
-3.57%
1M Prestazione:
-0.15%
6M Prestazione:
+27.08%
1 anno Prestazione:
+98.33%
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Nome
Madrigal Pharmaceuticals Inc
Settore
Industria
Telefono
404-380-9263
Indirizzo
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Confronta MDGL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MDGL
Madrigal Pharmaceuticals Inc
|
424.23 | 9.43B | 0 | -518.67M | -438.32M | -25.12 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-04 | Ripresa | H.C. Wainwright | Buy |
2025-02-28 | Aggiornamento | B. Riley Securities | Neutral → Buy |
2025-02-27 | Reiterato | H.C. Wainwright | Buy |
2024-06-28 | Iniziato | Cantor Fitzgerald | Neutral |
2024-06-11 | Iniziato | Wolfe Research | Outperform |
2024-04-22 | Iniziato | BofA Securities | Underperform |
2024-03-15 | Aggiornamento | B. Riley Securities | Sell → Neutral |
2024-03-06 | Iniziato | Citigroup | Buy |
2024-02-26 | Downgrade | B. Riley Securities | Neutral → Sell |
2022-12-20 | Reiterato | Oppenheimer | Outperform |
2022-12-19 | Reiterato | H.C. Wainwright | Buy |
2022-12-19 | Reiterato | Piper Sandler | Overweight |
2022-12-19 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
2022-07-08 | Downgrade | B. Riley Securities | Buy → Neutral |
2021-10-07 | Iniziato | Jefferies | Buy |
2021-08-06 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
2021-05-20 | Ripresa | Goldman | Buy |
2020-11-24 | Ripresa | Evercore ISI | Outperform |
2020-11-06 | Reiterato | H.C. Wainwright | Buy |
2020-07-31 | Iniziato | Piper Sandler | Overweight |
2020-06-05 | Iniziato | BMO Capital Markets | Market Perform |
2020-05-05 | Iniziato | Chardan Capital Markets | Buy |
2020-01-30 | Iniziato | Canaccord Genuity | Buy |
2020-01-09 | Aggiornamento | UBS | Neutral → Buy |
2019-11-07 | Reiterato | H.C. Wainwright | Buy |
2019-06-25 | Iniziato | Stifel | Hold |
2019-06-10 | Aggiornamento | B. Riley FBR | Neutral → Buy |
2019-02-28 | Reiterato | H.C. Wainwright | Buy |
2019-02-22 | Iniziato | SVB Leerink | Outperform |
2019-01-23 | Iniziato | UBS | Neutral |
2018-12-14 | Iniziato | Wolfe Research | Outperform |
2018-12-12 | Iniziato | B. Riley FBR | Neutral |
2018-11-19 | Downgrade | Raymond James | Mkt Perform → Underperform |
2018-11-16 | Aggiornamento | Evercore ISI | In-line → Outperform |
2018-09-04 | Iniziato | Citigroup | Buy |
2018-08-06 | Downgrade | Goldman | Buy → Neutral |
2018-06-28 | Iniziato | Raymond James | Mkt Perform |
Mostra tutto
Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie
What drives Madrigal Pharmaceuticals Inc YDO1 stock priceHigh Frequency Trading Trends & Small Budget Capital Investment - Early Times
What drives Madrigal Pharmaceuticals Inc stock priceSupport and Resistance Levels & Rapid Capital Trading - Early Times
Madrigal Pharmaceuticals Announces Positive Quality of Life Outcomes for Rezdiffra in NASH Treatment - MSN
What analysts say about Madrigal Pharmaceuticals Inc stockSupport Zone Identification & Unlock Long-Term Capital Growth Ideas - Early Times
Madrigal Pharmaceuticals Inc Stock Analysis and ForecastAutomated Trading Signals & Low Entry Capital Stocks - Early Times
Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS - The Globe and Mail
Strs Ohio Acquires Shares of 1,900 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals Grants Equity Awards to 76 New Employees - MSN
Analyst Downgrade: Is Madrigal Pharmaceuticals Inc. affected by consumer sentimentSell Signal & Consistent Profit Trading Strategies - خودرو بانک
Fund Flows: Is Diana Shipping Inc vulnerable to short sellers2025 Major Catalysts & Technical Buy Zone Confirmations - khodrobank.com
Treasury Yields: Will Madrigal Pharmaceuticals Inc. outperform during market ralliesQuarterly Portfolio Summary & Growth Focused Entry Point Reports - خودرو بانک
Bond Watch: Can Madrigal Pharmaceuticals Inc weather a recessionOptions Play & Safe Capital Growth Plans - خودرو بانک
Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth - MSN
How to read the order book for Madrigal Pharmaceuticals Inc.Profit Target & AI Enhanced Trading Alerts - newser.com
Value Recap: Can Madrigal Pharmaceuticals Inc stock double in the next year2025 Institutional Moves & Real-Time Market Sentiment Alerts - خودرو بانک
Smart Money: What is Madrigal Pharmaceuticals Incs TAM Total Addressable MarketJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - khodrobank.com
Growth Value: Does ENERR have pricing powerJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - khodrobank.com
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Madrigal Pharmaceuticals gains amid takeover speculation - MSN
Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN
Madrigal Pharmaceuticals announces grants of inducement awards - MarketScreener
76 New Hires: Madrigal Pharmaceuticals Awards 31.8K RSUs and Stock Options in MASH Drug Expansion - Stock Titan
Investment Report: What are Madrigal Pharmaceuticals Incs recent SEC filings showingBull Run & Daily Profit Focused Screening - خودرو بانک
Intech Investment Management LLC Purchases 1,696 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
EP Wealth Advisors LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Rhumbline Advisers Acquires 1,924 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Market Overview: Can Madrigal Pharmaceuticals Inc weather a recession2025 Volume Leaders & Safe Capital Growth Stock Tips - khodrobank.com
Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion - MSN
Growth Value: Will Madrigal Pharmaceuticals Inc outperform during market ralliesJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - خودرو بانک
Earnings Recap: Is Madrigal Pharmaceuticals Inc benefiting from innovation trendsStop Loss & Fast Entry and Exit Trade Plans - خودرو بانک
Market Review: What are Madrigal Pharmaceuticals Incs earnings expectationsEarnings Growth Summary & Weekly High Conviction Trade Ideas - خودرو بانک
Pullback Watch: Is Madrigal Pharmaceuticals Inc stock good for income investors2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک
Madrigal stock jumps 13% after Rezdiffra Q3 sales beat estimates - MSN
Downgrade Watch: What is the next catalyst for ATEXWeekly Gains Summary & Technical Confirmation Alerts - خودرو بانک
Aug PostEarnings: Is Madrigal Pharmaceuticals Inc stock forming a cup and handleLayoff News & Technical Buy Zone Confirmation - خودرو بانک
Short Squeeze: How is Capital City Bank Group Inc. managing supply chain issuesPortfolio Risk Report & Daily Stock Momentum Reports - خودرو بانک
Recap Report: Does Madrigal Pharmaceuticals Inc. stock benefit from AI growthJuly 2025 Patterns & Weekly Consistent Profit Watchlists - خودرو بانک
Woodline Partners LP Raises Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $3,243,740.77 in Stock - MarketBeat
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Rezdiffra’s Strong Q2 Sales and EU Approval - Sahm
Canaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - Defense World
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Madrigal Pharmaceuticals stock price target raised by Canaccord on MASH drug outlook - Investing.com Canada
Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 12-Month HighTime to Buy? - MarketBeat
What is HC Wainwright's Estimate for MDGL Q3 Earnings? - MarketBeat
Canaccord Genuity Boosts Madrigal Pharmaceuticals (MDGL) Price T - GuruFocus
Madrigal Pharmaceuticals Inc Azioni (MDGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Madrigal Pharmaceuticals Inc Azioni (MDGL) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Sibold William John | President and CEO |
Sep 09 '25 |
Sale |
445.63 |
7,279 |
3,243,741 |
102,474 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):